Thrombotic thrombocytopenia due to SARS-CoV-2 vaccination.
Thrombotic thrombocytopenia due to SARS-CoV-2 vaccination.
复制标题
DOI：
10.3949/ccjm.88a.ccc078
复制
发表时间：
2021-05-06
影响因子：
6.1
通讯作者：
McCrae, Keith R
中科院分区：
文献类型：
--
作者：
McCrae, Keith R
疫苗诱导的血栓性血小板减少症(VITT)在接种AztraZeneca ChAdOx1nCoV-19和Johnson and Johnson AD26后被报道。COV2.S疫苗。这份手稿简要概述了报告的病例、临床和实验室特征，以及目前对VITT发病机制的了解。作者还提出了一些尚未回答的问题，并指出了未来研究的方向。
Vaccine-induced thrombotic thrombocytopenia (VITT) has been reported after vaccination with the AztraZeneca ChAdOx1 nCoV-19 and the Johnson and Johnson Ad26. COV2.S vaccines. This manuscript provides a brief overview of reported cases, clinical and laboratory features, and current understanding of the pathogenesis of VITT. The author also poses unananswered questions and identifies directions for future study.